MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
The Lancet Diabetes & Endocrinology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

247 results · 1 filter active ·
Results by year
20132025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
247 works in the cohort · of 4,299,418page 1 of 5

Labels cover 3 of 247 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 247 of 247 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Definition and diagnostic criteria of clinical obesity
Francesco Rubino, David E. Cummings, Robert H. Eckel, Ricardo V. Cohen, John Wilding, Wendy A. Brown +49 more
2025· review· en· The Lancet Diabetes & Endocrinology· Health Professions
distilled prediction:candidate · metaresearch+research_integrityconsensus · none
1,324
citations
affno abstractunlabeled
Exercise management in type 1 diabetes: a consensus statement
Michael C. Riddell, Ian Gallen, Carmel E. Smart, Craig E. Taplin, Peter Adolfsson, Alistair Lumb +15 more
2017· review· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
890
citations
affno abstractunlabeled
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Christopher Sorli, Shin‐ichi Harashima, George Tsoukas, Jeffrey Unger, Julie Derving Karsbøl, Thomas K. Hansen +1 more
2017· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
707
citations
affno abstractunlabeled
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Marc S. Sabatine, Lawrence A. Leiter, Stephen D. Wiviott, Robert P. Giugliano, Prakash Deedwania, Gaetano Maria De Ferrari +10 more
2017· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · noneconsensus · none
596
citations
affno abstractunlabeled
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
David Z.I. Cherney, Bernard Zinman, Silvio E. Inzucchi, Audrey Koitka‐Weber, Michaela Mattheus, Maximilian von Eynatten +1 more
2017· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · noneconsensus · none
373
citations
affno abstractunlabeled
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, Pernille Poulsen +2 more
2014· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · noneconsensus · none
362
citations
affno abstractunlabeled
Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu, Fabienne Langlois, Dawn Shao Ting Lim, Elena V Varlamov, Шломо Мелмед
2022· review· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
258
citations

How this was built: Screen · Findings · About